Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Maven Capital Partners

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 172
Average round size
info
The average size of a deal this fund participated in
$5M
Portfolio companies 138
Rounds per year 10.75
Lead investments 80
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.20
Exits 12
Key employees 27
Stages of investment
Early Stage Venture
Private Equity
Seed

Areas of investment

  • Software
  • Information Technology
  • SaaS
  • Manufacturing
  • Analytics
Summary

Maven Capital Partners is the famous VC, which was founded in 2009. The fund was located in Europe if to be more exact in United Kingdom. The leading representative office of defined VC is situated in the Glasgow.

The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Maven Capital Partners, startups are often financed by Scottish Investment Bank, Par Equity, Development Bank of Wales. The meaningful sponsors for the fund in investment in the same round are Development Bank of Wales, Seneca Partners, NVM Private Equity. In the next rounds fund is usually obtained by Seneca Partners, Development Bank of Wales, Downing Ventures.

Among the most popular portfolio startups of the fund, we may highlight Global Risk Partners, Hiring Hub, ITS Technology Group. Among the most popular fund investment industries, there are Automotive, Biotechnology. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager.

The average startup value when the investment from Maven Capital Partners is 5-10 millions dollars. The fund is constantly included in 7-12 deals per year. The high activity for fund was in 2019. The real fund results show that this VC is 52 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this Maven Capital Partners works on 21 percentage points less the average amount of lead investments. The common things for fund are deals in the range of 1 - 5 millions dollars. The higher amount of exits for fund were in 2017.

Besides them, we counted 27 critical employees of this fund in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Maven Capital Partners:
Typical Co-investors
Maven Capital Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Maven Capital Partners:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United Kingdom
Funds with similar focus located in United Kingdom:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Carcinotech

Medical
$5M29 Jan 2024 -

Metrion Biosciences

Collaborative Consumption
Health Care
Life Science
Medical
Neuroscience
$5M20 Dec 2023 Cambridge, England, United Kingdom

Laverock Therapeutics

Biotechnology
Therapeutics
$18M28 Sep 2023 -

MarraBio

Biotechnology
$685K18 Sep 2023 Newcastle upon Tyne, North East, United Kingdom

Manufacture 2030

Information Technology
Internet
Manufacturing
$6M28 Mar 2023 Oxford, England, United Kingdom

Biorelate

Big Data
Biotechnology
Health Care
Life Science
Medical
$8M29 Nov 2022 Oldham, England, United Kingdom

Summize

Contact Management
Document Management
Legal
Legal Tech
Software
$6M25 Oct 2022 Manchester, Greater Manchester, United Kingdom

Bright

Analytics
Apps
Career Planning
Digital Media
Information Technology
Internet
Recruiting
SaaS
Staffing Agency
$4M20 Oct 2022 London, England, United Kingdom

Novatus Advisory

Financial Services
$5M11 Jul 2022 Hampshire, England, United Kingdom
News
Class Technologies Closes $105M Series B

– Class Technologies, an edtech platform, has raised a $105M Series B round.
– Led by the Softbank Vision Fund, the round also includes GSV Ventures, Emergence Capital, Maven Partners, Owl Ventures, Insight Partners, SWaN & Legend Venture Partners, Rise of the Rest Fund, Learn Capital, Reach Capital, Slow Ventures, Sound Ventures, Chimera Investment, Daher Capital, Guy Oseary, Bill Tai and Tom Brady.
– The company was founded by education software pioneer Michael Chasen.

Class Raises $105M in Series B Funding

– Class Technologies Inc. from Washington, DC develops a platform enhancing virtual and hybrid classrooms by adding teaching and learning tools to Zoom.
– Series B $105m round was led by SoftBank’s Vision Fund 2 and participated by GSV Ventures, Emergence Capital, Maven Partners, Owl Ventures, Insight Partners, SWaN & Legend Venture Partners, Revolution’s Rise of the Rest Fund, Learn Capital, Reach Capital, Slow Ventures, Sound Ventures, Chimera Investment, Daher Capital, Guy Oseary, Bill Tai, and Super Bowl champion and entrepreneur Tom Brady.
– The new investment will be used to accelerate growth and expand globally into new markets.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Maven Capital Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 172
Average round size 5M
Rounds per year 10.75
Peak activity year 2020
Lead investments 80
Follow on index 0.20
Exits 12
Group Appearance index 0.53

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Carcinotech

Medical
$5M29 Jan 2024 -

Metrion Biosciences

Collaborative Consumption
Health Care
Life Science
Medical
Neuroscience
$5M20 Dec 2023 Cambridge, England, United Kingdom

Laverock Therapeutics

Biotechnology
Therapeutics
$18M28 Sep 2023 -

MarraBio

Biotechnology
$685K18 Sep 2023 Newcastle upon Tyne, North East, United Kingdom

Manufacture 2030

Information Technology
Internet
Manufacturing
$6M28 Mar 2023 Oxford, England, United Kingdom

Biorelate

Big Data
Biotechnology
Health Care
Life Science
Medical
$8M29 Nov 2022 Oldham, England, United Kingdom

Summize

Contact Management
Document Management
Legal
Legal Tech
Software
$6M25 Oct 2022 Manchester, Greater Manchester, United Kingdom

Bright

Analytics
Apps
Career Planning
Digital Media
Information Technology
Internet
Recruiting
SaaS
Staffing Agency
$4M20 Oct 2022 London, England, United Kingdom

Novatus Advisory

Financial Services
$5M11 Jul 2022 Hampshire, England, United Kingdom
Crunchbase icon

Content report

The following text will be sent to our editors: